|
|
|
|
| Don't miss the next Cell & Gene Live discussion on how CAR-T manufacturing has advanced recently and where it's going. Host Tyler Menichiello welcomes CTMC's Jason Bock, Ph.D., Cartesian Therapeutics' Emily English, Ph.D., and former FDA-turned Dark Horse consultant and CMC Expert, Tal Salz, Ph.D., for this digital event happening Tuesday, August 27, at 11 AM ET. Registration is free thanks to the support of CPC. |
|
|
|
|
By Tyler Menichiello, contributing editor | Experts from last month’s Cell & Gene Live event discuss practical ways to utilize emerging technologies. |
|
|
|
|
In this segment, expert panelists explain the advanced analytics and process monitoring technologies utilized in cell therapy manufacturing and how they help improve process control and product quality. |
|
|
|
|
| How mRNA Technology Engineers Next-Generation Antibodies | Article | By Christian Cobaugh, Vernal Biosciences | Monoclonal antibodies (mAbs) stand as pivotal drug products and biochemical reagents in the 21st century. Explore how mRNA-encoded antigens could revolutionize antibody discovery. |
|
|
| 4 Questions To Ask Your Fill Finish Partner | Article | By Ramon Gonzalez, Ajinomoto Bio-Pharma Services | Reducing risk while maximizing API volume is critical during the fill finish phase of biopharmaceutical manufacturing. To ensure safety and quality, partner with an experienced fill finish provider. |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
